Serum levels of neurofilament light chain, neuron-specific enolase and S100 calcium-binding protein B during acute bacterial meningitis: a prospective cohort study

References

• Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467–492.
   PubMed Web of Science ®Google Scholar
• van de Beek D. Progress and challenges in bacterial meningitis. Lancet. 2012;380(9854):1623–1624.
   PubMed Web of Science ®Google Scholar
• Bodilsen J, Storgaard M, Larsen L, et al. Infectious meningitis and encephalitis in adults in Denmark: a prospective nationwide observational cohort study (DASGIB). Clin Microbiol Infect. 2018;24(10):1102 e1–e5.
   PubMed Web of Science ®Google Scholar
• Bijlsma MW, Brouwer MC, Kasanmoentalib ES, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis. 2016;16(3):339–347.
   PubMed Web of Science ®Google Scholar
• Castelblanco RL, Lee M, Hasbun R. Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. Lancet Infect Dis. 2014;14(9):813–819.
   PubMed Web of Science ®Google Scholar
• Hoffman O, Weber RJ. Pathophysiology and treatment of bacterial meningitis. Ther Adv Neurol Disord. 2009;2(6):1–7.
   PubMedGoogle Scholar
• Brouwer MC, van de Beek D. Management of bacterial central nervous system infections. Handb Clin Neurol. 2017;140:349–364.
   PubMedGoogle Scholar
• Koelman DLH, Brouwer MC, van de Beek D. Targeting the complement system in bacterial meningitis. Brain. 2019;142(11):3325–3337.
   PubMedGoogle Scholar
• Loughran AJ, Orihuela CJ, Tuomanen EI. Streptococcus pneumoniae: invasion and Inflammation. Microbiol Spectr. 2019;7(2). DOI:10.1128/microbiolspec.GPP3-0004-2018
   PubMed Web of Science ®Google Scholar
• Ribes S, Nessler S, Heide EC, et al. The early adaptive immune response in the pathophysiological process of pneumococcal meningitis. J Infect Dis. 2017;215(1):150–158.
   PubMed Web of Science ®Google Scholar
• Barichello T, Generoso JS, Simoes LR, et al. Role of microglial activation in the pathophysiology of bacterial meningitis. Mol Neurobiol. 2016;53(3):1770–1781.
   PubMed Web of Science ®Google Scholar
• Kastenbauer S, Winkler F, Fesl G, et al. Acute severe spinal cord dysfunction in bacterial meningitis in adults: MRI findings suggest extensive myelitis. Arch Neurol. 2001;58(5):806–810.
   PubMedGoogle Scholar
• Swartz MN. Bacterial meningitis: more involved than just the meninges. N Engl J Med. 1984;311(14):912–914.
   PubMed Web of Science ®Google Scholar
• Gerber J, Nau R. Mechanisms of injury in bacterial meningitis. Curr Opin Neurol. 2010;23(3):312–318.
   PubMed Web of Science ®Google Scholar
• Mook-Kanamori BB, Geldhoff M, van der Poll T, et al. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev. 2011;24(3):557–591.
   PubMed Web of Science ®Google Scholar
• Braun JS, Sublett JE, Freyer D, et al. Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest. 2002;109(1):19–27.
   PubMed Web of Science ®Google Scholar
• Baussart B, Cheisson G, Compain M, et al. Multimodal cerebral monitoring and decompressive surgery for the treatment of severe bacterial meningitis with increased intracranial pressure. Acta Anaesthesiol Scand. 2006;50(6):762–765.
   PubMed Web of Science ®Google Scholar
• Kramer AH, Bleck TP. Neurocritical care of patients with central nervous system infections. Curr Treat Options Neurol. 2008;10(3):201–211.
   PubMed Web of Science ®Google Scholar
• Larsen L, Nielsen TH, Nordstrom CH, et al. Patterns of cerebral tissue oxygen tension and cytoplasmic redox state in bacterial meningitis. Acta Anaesthesiol Scand. 2019;63(3):329–336.
   PubMed Web of Science ®Google Scholar
• Lambertsen KL, Soares CB, Gaist D, et al. Neurofilaments: the C-reactive protein of neurology. Brain Sci. 2020;10(1):56.
   PubMed Web of Science ®Google Scholar
• Khalil M, Teunissen CE, Otto M, Piehl F, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14(10):577–589.
   PubMed Web of Science ®Google Scholar
• Fyfe I. Neurofilament light chain - new potential for prediction and prognosis. Nat Rev Neurol. 2019;15(10):557.
   PubMed Web of Science ®Google Scholar
• Sejbaek T, Nielsen HH, Penner N, et al. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naive relapsing MS patients. J Neurol Neurosurg Psychiatry. 2019;90(12):1324–1330.
   PubMed Web of Science ®Google Scholar
• Asadollahi S, Heidari K, Taghizadeh M, et al. Reducing head computed tomography after mild traumatic brain injury: Screening value of clinical findings and S100B protein levels. Brain Inj. 2016;30(2):172–178.
   PubMed Web of Science ®Google Scholar
• Zetterberg H, Smith DH, Blennow K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol. 2013;9(4):201–210.
   PubMed Web of Science ®Google Scholar
• Cheng F, Yuan Q, Yang J, et al. The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis. PLoS One. 2014;9(9):e106680.
   PubMed Web of Science ®Google Scholar
• Pleines UE, Morganti-Kossmann MC, Rancan M, et al. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma. 2001;18(5):491–498.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.
   PubMed Web of Science ®Google Scholar
• Teunissen CE, Petzold A, Bennett JL, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73(22):1914–1922.
   PubMed Web of Science ®Google Scholar
• Gisslen M, Price RW, Andreasson U, et al. Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study. EBioMedicine. 2016;3:135–140.
   PubMed Web of Science ®Google Scholar
• Unden J, Ingebrigtsen T, Romner B, Scandinavian Neurotrauma Committee (SNC), et al. Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC Med. 2013;11:50.
   PubMed Web of Science ®Google Scholar
• Lu CH, Macdonald-Wallis C, Gray E, et al. Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. Neurology. 2015;84(22):2247–2257.
   PubMed Web of Science ®Google Scholar
• Shahim P, Gren M, Liman V, et al. Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Sci Rep. 2016;6:36791.
   PubMed Web of Science ®Google Scholar
• Matsushige T, Ichiyama T, Kajimoto M, et al. Serial cerebrospinal fluid neurofilament concentrations in bacterial meningitis. J Neurol Sci. 2009;280(1-2):59–61.
   PubMed Web of Science ®Google Scholar
• Beridze M, Sanikidze T, Shakarishvili R, et al. Selected acute phase CSF factors in ischemic stroke: findings and prognostic value. BMC Neurol. 2011;11(1):41.
   PubMedGoogle Scholar
• Bridel C, van Wieringen WN, Zetterberg H, et al. Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. 2019;76(9):1035.
   PubMed Web of Science ®Google Scholar
• Gaetani L, Blennow K, Calabresi P, et al. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019;90(8):870–881.
   PubMed Web of Science ®Google Scholar
• Zetterberg H. Neurofilament light: a dynamic cross-disease fluid biomarker for neurodegeneration. Neuron. 2016;91(1):1–3.
   PubMed Web of Science ®Google Scholar
• Disanto G, Barro C, Benkert P, the Swiss Multiple Sclerosis Cohort Study Group, et al. Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann Neurol. 2017;81(6):857–870.
   PubMed Web of Science ®Google Scholar
• Kuhle J, Barro C, Andreasson U, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med. 2016;54(10):1655–1661.
   PubMed Web of Science ®Google Scholar
• Al Nimer F, Thelin E, Nystrom H, et al. Comparative assessment of the prognostic value of biomarkers in traumatic brain injury reveals an independent role for serum levels of neurofilament light. PLoS One. 2015;10(7):e0132177.
   PubMed Web of Science ®Google Scholar
• Al Nimer F, Lindblom R, Strom M, et al. Strain influences on inflammatory pathway activation, cell infiltration and complement cascade after traumatic brain injury in the rat. Brain Behav Immun. 2013;27(1):109–122.
   PubMedGoogle Scholar
• Tiedt S, Duering M, Barro C, et al. Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke. Neurology. 2018;91(14):e1338–e47.
   PubMed Web of Science ®Google Scholar
• Pedersen A, Stanne TM, Nilsson S, et al. Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction. J Neurol. 2019;266(11):2796–2806.
   PubMed Web of Science ®Google Scholar
• Gattringer T, Pinter D, Enzinger C, et al. Serum neurofilament light is sensitive to active cerebral small vessel disease. Neurology. 2017;89(20):2108–2114.
   PubMed Web of Science ®Google Scholar
• Onatsu J, Vanninen R, Jakala P, et al. Serum neurofilament light chain concentration correlates with infarct volume but not prognosis in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2019;28(8):2242–2249.
   PubMed Web of Science ®Google Scholar
• Kuhle J, Kropshofer H, Haering DA, et al. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. 2019;92(10):e1007–e15.
   PubMed Web of Science ®Google Scholar
• Effenberger-Neidnicht K, Hartmann M. Mechanisms of hemolysis during sepsis. Inflammation. 2018;41(5):1569–1581.
   PubMed Web of Science ®Google Scholar
• Honda M, Tsuruta R, Kaneko T, et al. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J Trauma. 2010;69(1):104–109.
   PubMedGoogle Scholar
• Geisen U, Benk C, Beyersdorf F, et al. Neuron-specific enolase correlates to laboratory markers of haemolysis in patients on long-term circulatory support. Eur J Cardiothorac Surg. 2015;48(3):416–420. discussion 20.
   PubMed Web of Science ®Google Scholar
• Thelin EP, Jeppsson E, Frostell A, et al. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity. Crit Care. 2016;20:285.
   PubMed Web of Science ®Google Scholar
• Mercier E, Tardif PA, Cameron PA, et al. Prognostic value of neuron-specific enolase (NSE) for prediction of post-concussion symptoms following a mild traumatic brain injury: a systematic review. Brain Inj. 2018;32(1):29–40.
   PubMed Web of Science ®Google Scholar
• Bartek J, Jr., Thelin EP, Ghatan PH, et al. Neuron-specific enolase is correlated to compromised cerebral metabolism in patients suffering from acute bacterial meningitis; an observational cohort study. PLoS One. 2016;11(3):e0152268.
   PubMedGoogle Scholar
• Baker AJ, Rhind SG, Morrison LJ, et al. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. J Neurotrauma. 2009;26(8):1227–1240.
   PubMed Web of Science ®Google Scholar
• Shahrokhi N, Soltani Z, Khaksari M, et al. The serum changes of neuron-specific enolase and intercellular adhesion molecule-1 in patients with diffuse axonal injury following progesterone administration: a randomized clinical trial. Arch Trauma Res. 2016;5(3):e37005.
   PubMed Web of Science ®Google Scholar
• Koch MW, George S, Wall W, et al. Serum NSE level and disability progression in multiple sclerosis. J Neurol Sci. 2015;350(1-2):46–50.
   PubMed Web of Science ®Google Scholar
• Koch M, Mostert J, Heersema D, et al. Plasma S100beta and NSE levels and progression in multiple sclerosis. J Neurol Sci. 2007;252(2):154–158.
   PubMed Web of Science ®Google Scholar
• Goyal A, Failla MD, Niyonkuru C, et al. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. J Neurotrauma. 2013;30(11):946–957.
   PubMed Web of Science ®Google Scholar
• Petzold A, Keir G, Lim D, et al. Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res Bull. 2003;61(3):281–285.
   PubMed Web of Science ®Google Scholar
• Lins H, Wallesch CW, Wunderlich MT. Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections. Acta Neurol Scand. 2005;112(5):303–308.
   PubMed Web of Science ®Google Scholar
• Welch RD, Ellis M, Lewis LM, et al. Modeling the kinetics of serum glial fibrillary acidic protein, ubiquitin carboxyl-terminal hydrolase-L1, and S100B concentrations in patients with traumatic brain injury. J Neurotrauma. 2017;34(11):1957–1971.
   PubMed Web of Science ®Google Scholar
• Barateiro A, Afonso V, Santos G, et al. S100B as a potential biomarker and therapeutic target in multiple sclerosis. Mol Neurobiol. 2016;53(6):3976–3991.
   PubMed Web of Science ®Google Scholar
• Jonsson H, Johnsson P, Hoglund P, et al. Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth. 2000;14(6):698–701.
   PubMed Web of Science ®Google Scholar
• Barry DM, Millecamps S, Julien JP, et al. New movements in neurofilament transport, turnover and disease. Exp Cell Res. 2007;313(10):2110–2120.
   PubMed Web of Science ®Google Scholar